Related Experiment Videos
[Histoautoradiographic characteristics of candidiasis pneumonia in combination drug therapy]
Arkhiv Patologii
|January 1, 1992
Abstract:
The lungs and organs of guinea pigs infected with fungus Candida against the background of cyclophosphamide immunodeficiency and therapy with antibiotics were studied morphologically. Secondary immunodeficiency and dysbacteriosis are shown to influence considerably the ability of fungal cells to utilize DNA and RNA precursors (tritium-labelled thymidine and uridine). Historadioautography allowed one to evaluate functional state of the infectious agent and host cell responses.
Insights
Fungal infections in guinea pigs with weakened immune systems show altered nutrient use. Antibiotics and immunodeficiency impact how Candida utilizes DNA and RNA precursors.
Area of Science:
- Mycology
- Immunology
- Pathology
Context:
- Morphological study of guinea pig organs infected with Candida.
- Investigated the impact of cyclophosphamide-induced immunodeficiency and antibiotic therapy.
- Focused on the interaction between fungal pathogens and host responses.
Purpose:
- To investigate the influence of secondary immunodeficiency and dysbacteriosis on Candida's utilization of nucleic acid precursors.
- To evaluate the functional state of Candida cells and host responses using historadioautography.
Summary:
- Cyclophosphamide-induced immunodeficiency and antibiotic treatment significantly alter the ability of Candida fungal cells to utilize DNA and RNA precursors (thymidine and uridine).
- Historadioautography revealed changes in the functional state of the infectious agent and host cell responses in treated guinea pigs.
- Dysbacteriosis, induced by antibiotic therapy, plays a crucial role in modulating fungal precursor utilization.
Impact:
- Provides insights into the pathobiology of Candida infections under compromised immune conditions.
- Highlights the role of host-pathogen interactions and nutrient acquisition in fungal pathogenesis.
- Suggests potential targets for therapeutic interventions in opportunistic fungal infections.